BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31348274)

  • 1. MiR-520f acts as a biomarker for the diagnosis of lung cancer.
    Zhou Y; Shen S
    Medicine (Baltimore); 2019 Jul; 98(30):e16546. PubMed ID: 31348274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer.
    Zou Y; Jing C; Liu L; Wang T
    Medicine (Baltimore); 2019 Dec; 98(50):e17814. PubMed ID: 31852062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Value of Serum and Exhaled Breath Condensate miR-186 and IL-1β Levels in Non-Small Cell Lung Cancer.
    Xie H; Chen J; Lv X; Zhang L; Wu J; Ge X; Yang Q; Zhang D; Chen J
    Technol Cancer Res Treat; 2020; 19():1533033820947490. PubMed ID: 32851926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma.
    Chen X
    Medicine (Baltimore); 2019 Jun; 98(26):e16051. PubMed ID: 31261511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of MicroRNA-330 Correlates with the Radiation Sensitivity and Prognosis of Patients with Brain Metastasis from Lung Cancer.
    Jiang LP; Zhu ZT; Zhang Y; He CY
    Cell Physiol Biochem; 2017; 42(6):2220-2229. PubMed ID: 28817811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
    Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
    Wu J; Li L; Jiang C
    Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
    Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
    Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Circulating miR-324 for Prostate Cancer.
    Jin YY; Tong SQ; Tong M
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.